Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease

Background: Mitochondrial dysfunction has been identified as a pathophysiological hallmark of disease onset and progression in patients with Parkinsonian disorders. Besides the overall emergence of gene therapies in treating these patients, this highly relevant molecular concept has not yet been def...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasuhn, Jannik, Brüggemann, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623067/
https://www.ncbi.nlm.nih.gov/pubmed/34828446
http://dx.doi.org/10.3390/genes12111840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623067/
https://www.ncbi.nlm.nih.gov/pubmed/34828446
http://dx.doi.org/10.3390/genes12111840

Ejemplares similares